Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2006; 12(28): 4466-4472
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4466
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4466
Table 4 Incidence of pancreatic cancer cells in peripheral blood, bone marrow, and liver tissue
| Author | Yr | Incidence |
| Tada et al[71] | 1993 | Peripheral blood, K-ras 2/6 (33%) |
| Juhl et al[72] | 1994 | Bone marrow, immunostaining: 15/26 (58%) |
| Inoue et al[73] | 1995 | Liver tissue, K-ras: 13/17 (76%) |
| Nomoto et al[74] | 1996 | Peripheral blood, K–ras: postoperative period10/10 (100%) |
| Funaki et al[75] | 1996 | Peripheral blood, CEAmRNA: 3/9 (33%) |
| Aihara et al[76] | 1997 | Peripheral blood, Keratin 19m RNA: 2/38 (5%) |
| Miyazono et al[77] | 1999 | Peripheral blood, CEAmRNA: 13-21 (61.9%) |
| Uemura et al[78] | 2004 | Peripheral blood, K-ras: 9/26 (35%) |
- Citation: Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Inoue S, Takeda S. Oncological problems in pancreatic cancer surgery. World J Gastroenterol 2006; 12(28): 4466-4472
- URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4466.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i28.4466